Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junhang Tian

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Diabetes|February 6, 2024
Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in ChinaLixin Guo, Qi Pan, Zhifeng Cheng, et al.
Diabetes, Obesity & Metabolism|September 19, 2023
A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapyLinong Ji, Jinmiao Lu, Leili Gao, et al.
JAMA|June 7, 2026
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical TrialLeili Gao, Hongwei Jiang, Hanqing Cai, et al.
The New England Journal of Medicine|May 27, 2025
Once-Weekly Mazdutide in Chinese Adults with Obesity or OverweightLinong Ji, Hongwei Jiang, Yan Bi, et al.
The Lancet. Diabetes & Endocrinology|June 24, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialLinong Ji, Leili Gao, Haibo Xue, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Diabetes|February 6, 2024
Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in ChinaLixin Guo, Qi Pan, Zhifeng Cheng, et al.
Diabetes, Obesity & Metabolism|September 19, 2023
A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapyLinong Ji, Jinmiao Lu, Leili Gao, et al.
JAMA|June 7, 2026
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical TrialLeili Gao, Hongwei Jiang, Hanqing Cai, et al.
The New England Journal of Medicine|May 27, 2025
Once-Weekly Mazdutide in Chinese Adults with Obesity or OverweightLinong Ji, Hongwei Jiang, Yan Bi, et al.
The Lancet. Diabetes & Endocrinology|June 24, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialLinong Ji, Leili Gao, Haibo Xue, et al.
Pageof 2